NDC 71655-578 – Ebanga
Ansuvimab 400 mg/8mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC71655-578
Product details
- Brand name
- Ebanga
- Generic name
- Ansuvimab
- Labeler
- Emergent BioDefense Operations Lansing LLC
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761172
- Marketed since
- December 21, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Zaire Ebolavirus Glycoprotein-directed Antibody
Active ingredients
- Ansuvimab 400 mg/8mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 71655-578-03 | 1 CARTON in 1 BOX (71655-578-03) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01) | Dec 21, 2020 |
| 71655-578-04 | 4 CARTON in 1 BOX (71655-578-04) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01) | Dec 21, 2020 |
| 71655-578-08 | 8 CARTON in 1 BOX (71655-578-08) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01) | Dec 21, 2020 |